Project Start
Project End
Budget Start
1995-10-01
Budget End
1996-09-30
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Motoyama, K; Arima, T; Yu, S et al. (2000) The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Transplantation 69:285-93
Arima, T; Rehman, A; Flye, M W (1997) Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2. Transplant Proc 29:1305-6
Tu, Y; Arima, T; Flye, M W (1997) Effect of donor irradiation or recipient interleukin-2 treatment on survival of spontaneously accepted rat liver allografts. Transplant Proc 29:856-7
Lepley, D M; Gillanders, W E; Myers, N B et al. (1997) Biochemical and functional characterization of soluble multivalent MHC L(d)/Fc gamma 1 and L(d)/Fc mu chimeric proteins loaded with specific peptides. Transplantation 63:765-74
Sivasai, K S; Alevy, Y G; Duffy, B F et al. (1997) Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 64:427-32
Tu, Y; Arima, T; Flye, M W (1997) Effects of intrathymic tolerance on mouse heart and skin allograft acceptance. Transplant Proc 29:1063-4
Gillanders, W E; Arima, T; Tu, F et al. (1997) Evidence for clonal deletion and clonal anergy after intrathymic antigen injection in a transplantation model. Transplantation 64:1159-66
Tu, Y; Arima, T; Flye, M W (1997) Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation. Transplantation 63:177-81
Tu, Y; Rehman, A; Flye, M W (1997) CTLA4-Ig treatment prolongs rat orthotopic liver graft survival. Transplant Proc 29:1036-7
Motoyama, K; Arima, T; Lehmann, M et al. (1997) Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Surgery 122:213-9; discussion 219-20

Showing the most recent 10 out of 23 publications